Medical Therapy Before Carotid Endarterectomy: Changes Over a 13-Year Period and Comparison Between Asymptomatic and Symptomatic Patients

Abstract

We evaluated the evolution of chronic medical therapy in patients admitted for carotid endarterectomy (CEA) over a 13-year period and to analyze the difference in medical treatment between symptomatic and asymptomatic patients. A retrospective study was conducted on patients treated between 2002 and 2015. The use of antiplatelets (acetylsalicylic acid [ASA], ticlopidine, and clopidogrel), oral anticoagulant therapy (OAT), statins and antihypertensives (angiotensin-converting enzyme inhibitors [ACE-I]/angiotensin receptor blockers [ARBs], β-blockers [BB]) administration was evaluated. During the study period, 852 CEAs were performed in 681 (79.9%) asymptomatic patients. Prescription rate increased significantly for ASA (+29.2%), clopidogrel (+10.3%), statins (+60.8%), ACE-I/ARBs (+31.1%), and BB (+19.3%; all P _trend < .05). No significant modification was observed for ticlopidine and OAT (ticlopidine use was abandoned in the recent years, but this difference was not significant due to the small numbers). A lower medication intake was recorded for symptomatic patients when compared with asymptomatic patients, except for OAT and clopidogrel. Our analysis suggests that medical therapy has changed over the years for patients with carotid stenosis. Although this is a big step toward best medical therapy, preoperative drug therapy remains suboptimal in symptomatic patients.

Keywords

carotid disease carotid endarterectomy carotid artery stenosis medical treatment

Get full access to this article

View all access options for this article.

References

North American Symptomatic Carotid Endarterectomy Trialists’ Collaborative Group. The final results of the NASCET trial. N Engl J Med. 1998;339(20):1415–1425.

European Carotid Surgery Trialists’ Collaborative Group Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351(9113):1379–1387.

The Asymptomatic Carotid Atherosclerosis Study Group. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273(18):1421–1428.

Halliday

Mansfield

Marro

. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention on disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet. 2004;363(9420):1491–1502.

Naylor

Sillesen

Schroeder

. Clinical and imaging features associated with an increased risk of early and late stroke in patients with symptomatic carotid disease. Eur J Vasc Endovasc Surg. 2015;49(5):513–523.

Naylor

Schroeder

Sillesen

. Clinical and imaging features associated with an increased risk of late stroke in patients with asymptomatic carotid disease. Eur J Vasc Endovasc Surg. 2014;48(6):633–640.

Abbott

. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke. 2009;40(10): e573–e583.

Giannopoulos

Kakkos

Abbott

. Long-term mortality in patients with asymptomatic carotid stenosis: implications for statin therapy. Eur J Vasc Endovasc Surg. 2015;50(5):573–582.

Seshasai

Wijesuriya

Sivakumaran

. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172(3):209–216.

10.

Stoner

Defreitas

. Process of care for carotid endarterectomy: perioperative medical management. J Vasc Surg. 2010;52(1):223–231.

11.

Dripps

. New classification of physical status. Anesthesiol. 1963;24:111.

12.

Paraskevas

Veith

Mikhailidis

Liapis

. Appropriate patient selection for carotid revascularization procedures is urgently needed. Angiology. 2018;69(1):12–16.

13.

Sharis

Cannon

Loscalzo

. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med. 1998;129(5):394–405.

14.

Ono

Kurohara

Yoshihara

Shimamoto

Yamaguchi

. Agranulocytosis caused by ticlopidine and its mechanism. Am J Hematol. 1991;37(4):239–242.

15.

Burt

Dillon

Yoon

. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126(17):2105–2114.

16.

Jarari

Rao

Peela

. A review on prescribing patterns of antihypertensive drugs. Clin Hypertens. 2016;22:7.

17.

Narayan

Tordoff

Nishtala

. Temporal trends in the utilization of preventive medicines by older people: a 9-year population-based study. Arch Gerontol Geriatr. 2016;62:103–111.

18.

Abbott

Paraskevas

Kakkos

. Systematic review of guidelines for the management of asymptomatic and symptomatic carotid stenosis. Stroke. 2015;46(11):3288–3301.

19.

Constantinou

Jayia

Hamilton

. Best evidence for medical therapy for carotid artery stenosis. J Vasc Surg. 2013;58(4):1129–1139.

20.

Paciaroni

Bogousslavsky

. Antithrombotic therapy in carotid artery stenosis: an update. Eur Neurol. 2015;73(1–2):51–56.

21.

Markus

Droste

Kaps

. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation. 2005;111(17):2233–2240.

22.

Wong

Chen

. CLAIR study investigators. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010;9(5):489–497.

23.

Batchelder

Hunter

Cairns

Sandford

Munshi

Naylor

. Dual antiplatelet therapy prior to expedited carotid surgery reduces recurrent events prior to surgery without significantly increasing Peri-operative bleeding complications. Eur J Vasc Endovasc Surg. 2015;50(4):412–419.